Follow-up studies on glycosylated flavonoids and their complexes with vanadium: their anti-hyperglycemic potential role in diabetes

The present study sought to evaluate the hypoglycemic activities of free glycosylated flavonoids and flavonoid complexes with vanadium(IV), (VO(IV)), on glycemia in experimental diabetic rats. Besides free kaempferol-3,7-O-(alpha)-dirhamnoside and kaempferol-3-neohesperidoside, complexes of these flavonoids with VO(IV) were administered by different routes in order to compare the potency of the compounds as well as the efficacy of insulin or VO(IV) in lowering serum glucose. Wistar rats were made diabetic by alloxan. The glycemia was assessed at different times after the administering of compounds. The equilibrium constants were determined by potentiometric study and two species with VO(IV) are proposed at physiological pH, VOH(2)L(2) for kaempferitrin and VOHL for kaempferol-3-neohesperidoside. The latter exhibited hypoglycemic activity at all times examined with 50 and 100 mg/kg and the former reduced the glycemia from 0 to 6h by i.p. route. The administering of the complexes or 0.0146 mmol/kg VO(IV) resulted in a serum glucose-lowering effect over time in the case of i.p. treatment. A marked hypoglycemic effect was observed for 0.5IU of insulin (67.5%); 0.0146 mmol VO(IV) (16.8%); 0.0294 mmol kaempferitrin-VO(IV) (17.8%) and 0.0286 mmol kaempferol-3-neohesperidoside-VO(IV) (56.0%) at 3h after i.p. treatment when compared with respective zero time in diabetic groups. Kaempferol-3-neohesperidoside-VO(IV) was 2.5 times more effective than VO(IV), twice as effective as the free compound and three times more effective than kaempferitrin-VO(IV). This is of particular interest since kaempferol-3-neohesperidoside appears to represent a suitable ligand for VO(IV) to mimic the efficacy of insulin in lowering serum glucose levels.     

Polyoxoalkoxy molybdenum and vanadium clusters

While the chemistry of polyoxoanions has been extensively studied, the related polyoxoalkoxide clusters remain relatively unexplored. Recent investigations into the coordination chemistry of polyoxoanions with alkoxide ligands demonstrate the existence of a rich structural chemistry which is now emerging. The introduction of alkoxide ligands into polyoxoanion cores significantly expands the structural diversity of the cluster types and allows the isolation not only of fully-oxidized cores with all metal centers possessing d⁰ electronic configurations but of fully-reduced and mixed valence systems.     

Comparison of bipyridyl, maltol and kojic acid action as organic vanadium ligands on activity of galactosyltransferase (EC 2.4.1.38), some physiological parameters and ultrastructure of Golgi complexes in rat hepatocytes

The biochemical activity and morphology of control and streptozotocin-diabetic rat liver Golgi complexes were previously investigated by us under influence of some vanadium [V(IV)] compounds. The effectiveness of these derivatives depends on the kind of complexing ligands. This paper presents the investigation of the effect of bipyridyl, the ligand of a new vanadium compound, tested by us with maltol and kojic acid (two ligands studied by the present and other authors). The three ligands alone action was tested under the same experimental conditions as in the case of whole compounds with vanadium and applied to liver Golgi complexes of control rats. A preliminary study for maltol and kojic acid had been previously carried out by us parallel with tests of whole vanadium complexes, but valuable differences in biological action found in our condition of experiments suggested the extension of studies to include the two above-mentioned ligands and to compare the effects of the three investigated ligands. The supplementary part of the experiment focused mainly on the ultrastructure of Golgi complexes in hepatocytes. Four groups of animals were used: C - control rats, C + M (maltol), C + (ka)2 (kojic acid) and C + (bpy)2 (bipyridyl). The control rats received 0.09M NaCl as drinking liquid; all the other animals were given 3.6 mmol/L of appropriate ligand solution in 0.09M NaCl during 7 days. All the animals survived the experiments. Only in group C + (bpy)2 did the authors observe statistically significant differences as compared with the controls (group C). The differences were detected in physiological studies and manifested as body weight decreased by approximately 20% during the experiment, lower liquid (p<0.001) and food (p<0.01) intake and increase of free blood sugar level (p<0.01). The yield of Golgi membrane isolation decreased in this group (p<0.01). The main investigated biochemical parameter, i.e. the activity of liver Golgi marker enzyme - galactosyltransferase - was not statistically significantly changed in comparison with the controls in all the investigated groups of rats; a similar dispersion of individual results were found in the four groups. In the three experimental groups, ultrastructural observations demonstrated a predominance of cylindrical Golgi structures, which were haphazardly twisted in the majority of cases. Typically shaped structures were encountered sporadically. The ligands alone evoked numerous subcellular changes in hepatocytes; these alterations most frequently involved the mitochondria and endoplasmic reticulum. No such changes had been seen, or else they had been less advanced when complex vanadium compounds were employed in our earlier experiments. As it follows, the ligands alone were demonstrated to be much more toxic to morphology of control liver Golgi apparatus as compared to complex compounds, which showed the ability of the former to normalize Golgi complexes of diabetic animals.     

Neighbouring metal induced oxidative addition at the iron centre amongst the iron-arylpyridylphosphine complexes

Complexes of the type (η⁴-BuC₅H₅)Fe(CO)₂(P) (P = PPh₂Py 3, PPhPy₂4, PPy₃5; Py = 2-pyridyl) were satisfactorily prepared. Upon treatment of 3 with M(CO)₃(EtCN)₃ (M = Mo, 6a; W, 6b), the pyridyl N-atom could be coordinated to the metal M, which then eliminates a CO ligand from the Fe-centre and induced an oxidative addition of the endo-C-H of (η⁴-BuC₅H₅). This results in a bridged hydrido heterodimetallic complex [(η⁵-BuC₅H₄)Fe(CO)(μ-P,N-PPh₂Py)(μ-H)M(CO)₄] (M = Mo, 7a, 81%; W, 7b, 76%). The reaction of 4 or 5 with 6a,b did not give the induced oxidative addition, although these complexes contain more than one pyridyl N-atom. The reaction of 4 with M(CO)₄(EtCN)₂ (M = Mo, 9a; W, 9b) produced heterodimetallic complexes [(η⁴-BuC₅H₅)Fe(CO)₂(μ-P:N,N′-PPhPy₂)M(CO)₄] (M = Mo, 10a, 81%; W, 10b, 83%). Treatment of 5 with 6a,b gave [(η⁴-BuC₅H₅)Fe(CO)₂(μ-P:N,N′,N″-PPy₃)M(CO)₃] (M = Mo, 12a, 96%; W, 12b, 78%).     

Inhibitory effect of molybdenum and vanadium salts on aflatoxin B1 synthesis by Aspergillus flavus

The effects of the elements zinc, manganese, iron, copper, molybdenum, and vanadium, added in various salt forms, on mycelial weights and aflatoxin B1 accumulation in the mycelium of Aspergillus flavus were investigated in liquid shake cultures. Ammonium heptamolybdate, when added to a complete medium at concentrations of 50-100 mg/L, appreciably reduced aflatoxin B1 accumulation without affecting growth of the fungus. Sodium molybdate and sodium monovanadate also reduced aflatoxin B1 yields without affecting mycelial growth but to a lesser extent. The addition of zinc sulphate stimulated aflatoxin B1 production in all media used. The influence of the other trace elements on aflatoxin production depended on the level of trace elements present in the basal medium. In general, manganese chloride had a stimulatory effect, whereas copper sulphate depressed yields. Mycelial levels of aflatoxin had peaked and then declined before mycelial dry weights had reached maximum. High yields of aflatoxin B1 were obtained in media having a final pH as low as pH 2.8.     

Synthesis, characterization and biological properties of cobalt(II) complexes of 1,10-phenanthroline and maltol

The synthesis and characterization of two cobalt(II) complexes, Co(phen)(ma)Cl 1 and Co(ma)₂(phen) 2, (phen = 1,10-phenanthroline, ma⁻ = maltolate or 2-methyl-4-oxo-4H-pyran-3-olate) are reported herein. The complexes have been characterized by FTIR, CHN analysis, fluorescence spectroscopy, UV-visible spectroscopy, conductivity measurement and X-ray crystallography. The number of chelated maltolate ligands seems to influence their DNA recognition, topoisomerase I inhibition and antiproliferative properties.     

Titanium and vanadium complexes with tetraphenylimidodiphosphinate

Treatment of [Ti(OPrⁱ)₂Cl₂] with K(tpip) (tpip⁻ = [N(PPh₂O)₂]⁻) followed by chlorination with HCl afforded cis-[Ti(tpip)₂Cl]₂ (1). Reduction of 1 with Na/Hg in THF gave [Ti(tpip)₃] (2), which could also be prepared from [TiCl₃(THF)₃] and K(tpip). Recrystallization of [V(O)(tpip)₂] (3) from CH₂Cl₂-Et₂O in air afforded trinuclear [{V(O)}₃(μ-tpip)₃(μ-O)₃] (4). Treatment of [Cr(NBu^t)₂Cl₂] and [Cr(NBu^t)Cl₃(dme)] (dme = 1,2-dimethoxyethane) with [Ag(tpip)]₄ led to isolation of [Cr(tpip)₃] (6) and [Cr(NBu^t)(tpip)₂Cl] (7), respectively. The Ti- and V-tpip complexes are capable of catalyzing oxidation of sulfides with tert-butyl hydroperoxide and H₂O₂. The crystal structures of 1, 2, and 4 have been determined.     

Alpha-glucosidase inhibitory effect of anti-diabetic metal ions and their complexes

We found alpha-glucosidase inhibitory (α-GI) effect of metal ions and their complexes which showed the high blood glucose lowering effect in diabetic model animals. The Cu(II) ion and its complexes showed strong α-GI activity greater than clinically used acarbose in in vitro studies. Furthermore, in in vivo experiments, α-GI action was newly discovered in normal ddy mice. These results suggested that one of action mechanisms of the anti-diabetic metal ions and complexes is related to the α-GI effects.     

Self-assembly of four three-dimensional reduced molybdenum(V) phosphates decorated with transitional metal complexes

Four new three-dimensional materials built from reduced molybdenum(V) phosphates as building blocks and transitional metal (Co, Zn and Cd) complexes as linkers, (Hbpy)₂[Co(bpy)(H₂O)]₂[Co(H₂PO₄)₂ (HPO₄)₆(MoO₂)₁₂(OH)₆] (1), [Co(H₂O)₄]₂[Co(Hbpy)(H₂O)]₂[Co(bpy)][Co(HPO₄)₄(PO₄)₄(MoO₂)₁₂(OH)₆] · 6H₂O (2), Na₂[Zn(Hbpy)(H₂O)₂]₂[Zn(Hbpy)]₂[Zn(HPO₄)₂(PO₄)₆(MoO₂)₁₂(OH)₆] · 4H₂O (3), (H₂bpy)₂[Cd(bpy)(H₂O)]₂[Cd(bpy)(H₂O)₂]₂[Cd(HPO₄)₄(PO₄)₄(MoO₂)₁₂(OH)₆] · 2H₂O (4) (bpy = 4,4′-bipyridine), have been synthesized and characterized by elemental analyses, IR, TG, and single crystal X-ray diffraction. The 3-D framework of 1 is constructed from Co[P₄Mo₆]₂ dimers bonded together with [Co(bpy)]_n coordination polymer chains. In compound 2, the Co[P₄Mo₆]₂ dimers are linked by both [Co(bpy)] complex chains and the cobalt dimers to form a 3-D framework. Compounds 1 and 2 represent the first examples of reduced molybdenum(V) phosphates decorated with transition metal complexes chains. The 3-D framework of 3 is constructed from Zn[P₄Mo₆]₂ dimers bonded together with [Zn(bpy)] coordination complexes and [Zn(bpy)(H₂O)₂] complexes. In compound 4, the Cd[P₄Mo₆]₂ dimers are coordinated with [Cd(bpy)(H₂O)] and [Cd(bpy)(H₂O)₂] complexes to construct a 3-D structure. To our best knowledge, it is the first time that linear ligand 4,4′-bpy molecules have been grafted into the backbone of reduced molybdenum phosphates. Furthermore, the magnetic properties of compounds 1 and 2 are reported.     

Model complexes for amavadine,a vanadium natural product

Amavadine is a vanadium natural product from the mushroom Amanita muscaria. Earlier reports have characterized the compound as a vanadyl (VO²⁺) complex with two N-hydroxy-αα-iminodipropionic acid ligands, but no hypothesis as to its function has yet been put forward. We report here the synthesis, isolation, and properties of bis(iminodiacetato)oxovanadium(IV) and bis(αα-iminodipropionato)oxovanadium(IV). The complex bis(ββ-iminodipropionato)oxovanadium(IV) has been prepared in solution. These complexes serve as models for Amavadine. The structures of the models are analogous to that of Amavadine, with two bidentate, singly charged ligands bonding through one oxygen and one nitrogen atom. The visible spectra suggest the possibility of 1:1 complexes in solution in addition to the 2:1 ligand to metal complexes. Preliminary electrochemical data suggest reversible V(IV) ? V(III) couples.     

Sensitization of Escherichia coli to nisin by maltol and ethyl maltol

F. SCHVED, M.D. PIERSON AND B.J. JUVEN. 1996. When used separately, 20 mmol 1^-1 maltol or 1600 AU ml^-1 nisin resulted in a 0–0.6 log₁₀ reduction in viable counts of Escherichia coli in a buffer system. However, when added in combination they yielded a 1.8–5. 5–log-cycle reduction in viable counts of E. coli at pH 5.0 and 6.8 respectively. It is postulated that maltol (and ethyl maltol) destabilizes the cell outer membrane by chelation of Mg²⁺ and/or Ca²⁺, thus permeabilizing the E. coli cell to nisin.     

Chloro-substituted dipicolinate vanadium complexes: Synthesis, solution, solid-state, and insulin-enhancing properties

Three vanadium complexes of chlorodipicolinic acid (4-chloro-2,6-dipicolinic acid) in oxidation states III, IV, and V were prepared and their properties characterized across the oxidation states. In addition, the series of hydroxylamido, methylhydroxylamido, dimethylhydroxylamido, and diethylhydroxylamido complexes were prepared from the chlorodipicolinato dioxovanadium(V) complex. The vanadium(V) compounds were characterized in solution by ⁵¹V and ¹H NMR and in the solid-state by X-ray diffraction and ⁵¹V NMR. Density Functional Theory (DFT) calculations were performed to evaluate the experimental parameters and further describes the electronic structure of the complex. The small structural changes that do occur in bond lengths and angles and partial charges on different atoms are minor compared to the charge features that are responsible for the majority of the electric field gradient tensor. The EPR parameters of the vanadium(IV) complex were characterized and compared to the corresponding dipicolinate complex. The chemical properties of the chlorodipicolinate compounds are discussed and correlated with their insulin-enhancing activity in streptozoticin (STZ) induced diabetic Wistar rats. The effect of the chloro-substitution on lowering diabetic hyperglycemia was evaluated and differences were found depending on the compounds oxidation state similar as was observed for the vanadium III, IV and V dipicolinate complexes (P. Buglyo, D.C. Crans, E.M. Nagy, R.L. Lindo, L. Yang, J.J. Smee, W. Jin, L.-H. Chi, M.E. Godzala III, G.R. Willsky, Inorg. Chem. 44 (2005) 5416-5427). However, a linear correlation of oxidation states with efficacy was not observed, which suggests that the differences in mode of action are not simply an issue of redox equivalents. Importantly, our results contrast the previous observation with the vanadium-picolinate complexes, where the halogen substituents increased the insulin-enhancing properties of the complex (T. Takino, H. Yasui, A. Yoshitake, Y. Hamajima, R. Matsushita, J. Takada, H. Sakurai, J. Biol. Inorg. Chem. 6 (2001) 133-142).     

Transition metal nitrosyls as nitrosylation agents. IV. 51V NMR characteristics of dinitrosyl and carbonylmononitrosyl vanadium complexes

The action of [Co(X)(NO)₂]₂ (X = Cl, Br, L) on [V(H)(CO)_6?nL_n] (L = 1/ndi- and tritertiary phosphine; n = 2, 3) in thf yields [V(CO)_5?n(NO)L₂] and [V(NO)₂(thf)₄]X as the two main products. Thf is easilty replaced by other ligands L′, leading to the complexes cis-[V(NO)₂(thf)_4?nL′_n]X, where n = 1 to 4. In the case of L′= CNR (R = Cy, iPr, tBu), the species [VX(NO)₂L′₃] are formed. The presence of X in the first coordination sphere is established by the normal halogen dependence (Cl < Br < I) of ⁵¹V shielding.δ(⁵¹V) values have been obtained for the two series of complexes and compared with δ of other nitrosylvanadium species, including [VX(NO)L′₄]X. for [V(NO)₂L′₄]br, ⁵¹V shielding increases in the sequence {O} < {S} < NR₃ < NCMe < AsEt₃ < SbEt₃ < PEt₂Ph < P(OMe)₃ < CNR, reflecting a general increase of shielding as the polarizability of the ligand function increases and its electronegativity decreases. Superimposed effects arising from electronic influences (PEtPh₂) < PMe₃ < P(OMe)₃ and steric conditions (chelate-4 ring < 7 ring < 6 ring < 5 ring) are also discussed. Steric factors are especially pronounced in the [V(CO)₃(NO)Ph₂P(CH₂)_mPPh₃] series (m = 1–4). The thermo-labile parent compound, [V(CO)₅NO], has been characterized by its δ(⁵¹V) = ?1489 ppm at 245 K.     

Ferrocenyl-substituted allenylidene complexes of chromium, molybdenum and tungsten: Synthesis, structure and reactivity

Bis(ferrocenyl)-substituted allenylidene complexes, [(CO)₅MCCCFc₂] (1a-c, Fc = (C₅H₄)Fe(C₅H₅), M = Cr (a), Mo (b), W (c)) were obtained by sequential reaction of Fc₂CO with Me₃Si-CCH, KF/MeOH, n-BuLi, and [(CO)₅M(THF)]. For the synthesis of related mono(ferrocenyl)allenylidene chromium complexes, [(CO)₅CrCCC(Fc)R] (R = Ph, NMe₂), three different routes were developed: (a) reaction of the deprotonated propargylic alcohol HCCC(Fc)(Ph)OH with [(CO)₅Cr(THF)] followed by desoxygenation with Cl₂CO, (b) Lewis acid induced alcohol elimination from alkenyl(alkoxy)carbene complexes, [(CO)₅CrC(OR)CHC(NMe₂)Fc], and (c) replacement of OMe in [(CO)₅CrCCC(OMe)NMe₂] by Fc. Complex 1a was also formed when the mono(ferrocenyl)allenylidene complex [(CO)₅CrCCC(Fc)NMe₂] was treated first with Li[Fc] and the resulting adduct then with SiO₂. The replacement route (c) was also applied to the synthesis of an allenylidene complex (7a) with a CC spacer in between the ferrocenyl unit and C_γ of the allenylidene ligand, [(CO)₅CrCCC(NMe₂)-CCFc]. The related complex containing a CHCH spacer (9a) was prepared by condensation of [(CO)₅CrCCC(Me)NMe₂] with formylferrocene in the presence of NEt₃. The bis(ferrocenyl)-substituted allenylidene complexes 1a-c added HNMe₂ across the C_α-C_β bond to give alkenyl(dimethylamino)carbene complexes and reacted with diethylaminopropyne by regioselective insertion of the CC bond into the C_β-C_γ bond to afford alkenyl(diethylamino)allenylidene complexes, [(CO)₅MCCC(NEt₂)CMeCFc₂]. The structures of 5a, 7a, and 9a were established by X-ray diffraction studies.     

Genetic evidence for an Azotobacter vinelandii nitrogenase lacking molybdenum and vanadium.

We have constructed a strain of Azotobacter vinelandii which has deletions in the genes for both the molybdenum (Mo) and vanadium (V) nitrogenases. This strain fixed nitrogen in medium that did not contain Mo or V. Growth and nitrogenase activity were inhibited by Mo and V. In highly purified medium, growth was limited by iron. Addition of other metals (Co, Cr, Cu, Mn, Ni, Re, Ti, W, and Zn) did not stimulate growth. Like the V-nitrogenase, the nitrogenase synthesized by the double deletion strain reduced acetylene to both ethylene and ethane (C2H6/C2H4 ratio, 0.046). There was an approximately 10-fold increase in ethane production when Mo was added to the deletion strain grown in medium lacking Mo and V. This change in reactivity may be due to the incorporation of an Mo-containing cofactor into the nitrogenase synthesized by the double-deletion strain. A strain synthesizing the V-nitrogenase did not show a similar increase in ethane production. The growth characteristics of the double-deletion strain, together with the metal composition reported for a nitrogenase isolated from a tungstate-tolerant strain lacking genes for the molydenum enzyme grown in the absence of Mo and V (J. R. Chisnell, R. Premakumar, and P. E. Bishop, J. Bacteriol. 170:27-33, 1988) show that A. vinelandii can synthesize a nitrogenase which lacks both Mo and V. Reduction of dinitrogen by nitrogenase can therefore occur at a center lacking both these metals.     

Synthesis and anti-hyperglycemic activity of hesperidin derivatives

A series of hesperidin derivatives were prepared and identified by IR, ¹H NMR, and MS spectra. These compounds were evaluated in vitro and in vivo based on α-glucosidase inhibition, glucose consumption of HepG2 cells, and blood glucose level in streptozotocin-induced diabetic mice. The results revealed that all the compounds exhibited anti-hyperglycemic activities. The inhibition at 10^?3 M of compounds 3 and 7a on α-glucosidase were 55.02% and 53.34%, respectively, as compared to 54.80% by acarbose. Treated by compound 3 and the reference drug metformin, glucose consumption of HepG2 cell were 1.78 and 2.11 mM, respectively. After the streptozotocin-induced diabetic mice were oral administrated with compound 3 at 100 mg kg^?1 d^?1 for 10 days, the blood glucose level of 3 treated mice (13.23 mM, P <0.05) showed significant difference when compared to model control (23.03 mM). Thus, compound 3 exhibited promising anti-hyperglycemic activity.